多学科的方法为临床有效的癌症类疫苗铺平了道路
Bansari A Shah1, James A Holden2, Jason C Lenzo3
1ACTV Research Group, Melbourne Dental School, Division of Basic and Clinical Oral Sciences, Royal Dental Hospital, and The Graeme Clark Institute, The University of Melbourne, Carlton, VIC, Australia.
NPJ vaccines
|April 9, 2025
概括
新的类疫苗旨在通过克服免疫抑制瘤微环境来增强细胞毒性T淋巴细胞 (CTL) 对癌症的反应. 本综述探讨了设计有效的基于的癌症免疫疗法的新策略.
科学领域:
- 癌症免疫学 癌症免疫学
- 免疫治疗是一种免疫疗法.
- 疫苗的研发工作正在进行中.
背景情况:
- 细胞毒性CD8+T淋巴细胞 (CTL) 细胞对于抗瘤免疫是至关重要的,但癌细胞可以通过免疫抑制瘤微环境 (TME) 逃避它们.
- 基于的疫苗,包括具有T辅助细胞表位和免疫刺激剂的多疫苗,正在研究利用CTL反应用于癌症免疫治疗.
- 过去的类疫苗在临床上取得了有限的成功,但最近癌症免疫学和疫苗设计方面的进展带来了新的乐观.
研究的目的:
- 审查基于的癌症免疫治疗中的新策略.
- 探索类疫苗如何诱导和增强CTL效应和记忆反应.
- 讨论诸如主要基因相容综合体 (MHC) 限制和免疫抑制性TME等挑战,以及疫苗如何克服这些挑战.
主要方法:
- 关于类疫苗设计,癌症免疫学和临床结果的当前文献的审查.
- 讨论CTL反应背后的机制及其通过疫苗的增强.
- 分析应对MHC限制和TME相关免疫抑制的策略.
主要成果:
- 最近在了解癌症免疫学和类疫苗设计方面的进展导致了新的策略.
- 基于的疫苗有望克服以前方法的局限性,并增强抗瘤免疫力.
- 解决MHC限制和TME免疫抑制是成功开发疫苗的关键.
结论:
- 新型类疫苗策略通过刺激强大的CTL反应,显示出有效的癌症免疫疗法的潜力.
- 克服MHC限制和免疫抑制TME等挑战对于临床成功至关重要.
- 整合化学,免疫学和临床研究对于推进基于的癌症疫苗至关重要.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.6K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.4K
相关概念视频
01:30Cancer Vaccines
278
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
278
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K